The FDA has approved a biosimilar of pertuzumab which is indicated for multiple breast cancer settings. The FDA has approved ...

Nurse-led telehealth follow-ups may increase emotional well-being for survivors of ovarian cancer, according to data from a ...

Panelists discuss how effective caregivers should join support groups, maintain detailed records of symptoms and medications, ...

JADPRO Live 2025 provides a platform for leaders in oncology advanced practice to share research and best practices with ...

Panelists discuss how specific talquetamab-related side effects like skin peeling, nail changes, and rashes can be ...

Panelists discuss how caregivers can navigate the initial shock of a myeloma diagnosis by seeking reliable information from ...

Panelists discuss how patients can maintain nutrition during talquetamab treatment by focusing on texture and food ...

Panelists discuss how comprehensive patient education materials and manufacturer resources help patients prepare for and ...

Panelists discuss how successful talquetamab treatment requires coordinated care between inpatient and outpatient teams, ...

Panelists discuss how expectations for treatment outcomes can become more positive over time through experience with multiple ...

Panelists discuss how patients beginning talquetamab should maintain a positive attitude, prepare thoroughly with educational ...

What she initially dismissed as stress or a complication of her existing hormone treatments with Turner syndrome soon led to ...